Table 1.
Baseline Infrastructure for Screening and Management of Cervical Precancerous Lesions
| Parameter | AIIMS ND | GKNM | AIIMS R | PGIMER | SJH | MGIMS |
| Site 1 | Site 2 | Site 3 | Site 4 | Site 5 | Site 6 | |
| Type and no of screening tests done/ day | ||||||
| Pap Smear | 13-15 | 3-8 | 4 | 15-20 | 20-25 | 15-16 |
| Human Papilloma Virus Deoxyribonucleic acid (HPV DNA) | 1-2 | careHPV in community |
NA | NA | NA | NA |
| Visual Inspection with Acetic acid (VIA) | 0 | 3-8 | 6 | - | 12-13 | 7 |
| Co-testing | 2-3 | - | - | - | 0 | - |
| Separate room for counselling | None | None | Table in waiting area |
None | None | 1 |
| Awareness Aids | ||||||
| 1. Audiovisual | Yes, not operational | Yes | No | Yes | Yes | Yes |
| 2. Flash Cards | No | Yes | No | No | Yes | No |
| 3. Posters | No | Yes | No | Yes | Yes | Yes |
| No. of dedicated staff available to provide counselling | 0 | 0 | 0 | 0 | 0 | 2 |
Abbreviations: VIA, Visual Inspection with Acetic acid; HPV DNA, Human Papilloma Virus Deoxyribonucleic acid